Johnson & Johnson Financial Chief Sees ‘Clear Line of Sight’ to Double-Digit Growth by 2030

The pharma giant and medical device posts earnings and sales that beat analysts’ estimates.
Zacks Investment Research on MSN

J&J targets double-digit growth by 2030 despite Stelara drag

Johnson & Johnson’s JNJ CEO Joaquin Duato said on the April 14 first-quarter conference call that the company has “line of ...